Therapeutic immunosuppression of T cells
β
Herman Waldmann; Stephen P. Cobbold; David Wraith; John Isaacs
π
Article
π
1992
π
Elsevier Science
π
English
β 741 KB
Current immunosuppressive therapy carries a range of unwanted side effects, and tends to penalize the whole immune system. It is desirable to develop therapies that are more selective for antigen-reactive cells. As T lymphocytes use a wide range of surface receptors to interact with antigen-bearing